Covered recipient · General Payments record
FREDRICK C HAYEK
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$7,745.09
- Reported across 486 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $367.70 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $164.05 | 4 |
| Amgen Inc. | $62.09 | 4 |
| Acerta Pharma LLC | $50.87 | 3 |
| PFIZER INC. | $33.10 | 2 |
| Lilly USA, LLC | $22.11 | 1 |
| Almatica Pharma Inc. | $19.99 | 1 |
| Xeris Pharmaceuticals, Inc. | $15.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Almatica Pharma LLC | $19.99 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137565453 | CMS |
| Amgen Inc. | $19.40 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117273959 | CMS |
| Amgen Inc. | $13.11 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117273961 | CMS |
| Amgen Inc. | $14.21 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117273963 | CMS |
| Amgen Inc. | $15.37 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117273965 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.93 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104657179 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.29 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105704732 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.65 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104759110 | CMS |
| GlaxoSmithKline, LLC. | $14.00 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116109006 | CMS |
| GlaxoSmithKline, LLC. | $8.11 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116606914 | CMS |
| GlaxoSmithKline, LLC. | $18.39 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116567378 | CMS |
| GlaxoSmithKline, LLC. | $123.55 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116145054 | CMS |
| Lilly USA, LLC | $22.11 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134992240 | CMS |
| PFIZER INC. | $16.11 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131799269 | CMS |
| PFIZER INC. | $16.99 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131807761 | CMS |
| Xeris Pharmaceuticals, Inc. | $15.49 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144595042 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.